Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- The pathogenesis of COVID-19 mediated by complement activation
- Indicators for complement activation in COVID-19
- The interaction between coagulation and complement cascades
- When to treat patients with anti-complement drugs
Biography
Dr. Jeffrey Laurence is a Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medical College, Attending Physician at New York Presbyterian Hospital, and Director of the Laboratory for AIDS Virus Research at those institutions. He is the Senior Scientist for Programs at amfAR, The Foundation for AIDS Research (co-founded by Dr. Mathilde Krim and Dame Elizabeth Taylor). He is also Editor-in-Chief of Translational Research (the Journal of Lab and Clinical Medicine) and for AIDS Patient Care and STDs. His current research focuses on mechanisms of HIV and HIV-treatment-associated cardiovascular and renal disease, the thrombotic microangiopathies associated with complement activation, and microvascular endothelial cell injury in HIV and other disorders including, most recently, COVID-19.
Dr. Laurence received his B.A. summa cum laude from Columbia University in 1972, and his M.D. with honors from the University of Chicago Pritzker School of Medicine in 1976. He was elected a Rhodes Scholar to Oxford University in 1973 and was a Henry Luce Scholar at the Institute for Cancer Research in Osaka, Japan, from 1974-1975. He completed a residency in internal medicine, followed by fellowships in hematology and oncology at The New York Hospital and a research fellowship in immunology at The Rockefeller University, where he first became involved in AIDS.
Dr. Laurence is a recipient of the Clinician-Scientist Award of the American Heart Association, the William S. Paley Fellowship in Academic Medicine, and an “Award of Vision” from the Red Ribbon AIDS Foundation. He is a member of the American Society for Clinical Investigation.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Laurence, J. (2021, January 20). Complement activation in COVID-19 [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/JPGE9884.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jeffrey Laurence has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)